We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.37%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$721M
AUM Growth
+$4.82M
(+0.67%)
Cap. Flow
-$95.8M
Cap. Flow
% of AUM
-13.27%
Top 10 Holdings %
Top 10 Hldgs %
17.52%
Holding
180
New
72
Increased
21
Reduced
42
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Celsius Holdings
CELH
|
+$9.1M |
| 2 |
Extreme Networks
EXTR
|
+$8.8M |
| 3 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$8.76M |
| 4 |
BLD
TopBuild
BLD
|
+$8.58M |
| 5 |
Harmonic Inc
HLIT
|
+$8.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Impinj
PI
|
+$15.4M |
| 2 |
PagerDuty
PD
|
+$13.9M |
| 3 |
SiTime
SITM
|
+$10.8M |
| 4 |
Natera
NTRA
|
+$10.7M |
| 5 |
Evolent Health
EVH
|
+$10.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.23% |
| 2 | Industrials | 24.45% |
| 3 | Healthcare | 18.28% |
| 4 | Consumer Discretionary | 12.57% |
| 5 | Consumer Staples | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
The Bancorp
TBBK
$2.98B
| $2.45M | 0.34% |
+74,990
| New | +$2.31M |
|
102
Axsome Therapeutics
AXSM
$10.9B
| $2.39M | 0.33% |
+33,325
| New | +$2.46M |
|
103
Construction Partners
ROAD
$5.68B
| $2.38M | 0.33% |
+75,895
| New | +$2.17M |
|
104
Schrodinger
SDGR
$1.35B
| $2.36M | 0.33% |
+47,180
| New | +$1.59M |
|
105
Napco Security Technologies
NSSC
$1.46B
| $2.2M | 0.31% |
+63,615
| New | +$2.22M |
|
106
Kirby Corp
KEX
$7.13B
| $2.2M | 0.31% |
28,595
-4,155
| -13% | -$299K |
|
107
Procept Biorobotics
PRCT
$1.11B
| $2.18M | 0.3% |
+61,730
| New | +$2.04M |
|
108
Xometry
XMTR
$5.01B
| $2.18M | 0.3% |
+102,820
| New | +$1.8M |
|
109
Advanced Energy
AEIS
$13.1B
| $2.16M | 0.3% |
+19,385
| New | +$1.85M |
|
110
CONMED
CNMD
$1.48B
| $2.16M | 0.3% |
+15,885
| New | +$1.94M |
|
111
nLIGHT
LASR
$4.33B
| $2.13M | 0.3% |
+138,270
| New | +$1.69M |
|
112
Fabrinet
FN
$19.5B
| $2.1M | 0.29% |
+16,205
| New | +$1.73M |
|
113
Urban Outfitters
URBN
$6.65B
| $2.05M | 0.28% |
+61,980
| New | +$1.81M |
|
114
Digi International
DGII
$3.12B
| $2.02M | 0.28% |
51,280
+24,070
| +88% | +$828K |
|
115
Krystal Biotech
KRYS
$9.6B
| $1.98M | 0.27% |
+16,845
| New | +$1.72M |
|
116
Harmony Biosciences
HRMY
$2.24B
| $1.93M | 0.27% |
+54,800
| New | +$1.89M |
|
117
Cerence
CRNC
$409M
| $1.72M | 0.24% |
+58,935
| New | +$1.62M |
|
118
RxSight
RXST
$248M
| $1.7M | 0.24% |
+59,075
| New | +$1.31M |
|
119
Carpenter Technology
CRS
$28.2B
| $1.65M | 0.23% |
29,470
-34,840
| -54% | -$1.7M |
|
120
SI-BONE Inc
SIBN
$800M
| $1.62M | 0.22% |
+60,055
| New | +$1.46M |
|
121
Ollie's Bargain Outlet
OLLI
$4.72B
| $1.61M | 0.22% |
+27,810
| New | +$1.71M |
|
122
Duolingo
DUOL
$5.73B
| $1.59M | 0.22% |
+11,145
| New | +$1.6M |
|
123
Crocs
CROX
$6.46B
| $1.59M | 0.22% |
14,100
-80,350
| -85% | -$9.58M |
|
124
Xponential Fitness
XPOF
$267M
| $1.58M | 0.22% |
91,430
-66,835
| -42% | -$1.89M |
|
125
MasTec
MTZ
$21B
| $1.52M | 0.21% |
12,915
-36,605
| -74% | -$3.58M |
|
Similar funds
PIM
EH
TPWA
STT
VC
CF
IVLAV
MHC
Lisanti Capital Growth's Q2 2023 Portfolio in Review
As of Q2 2023, Lisanti Capital Growth held 180 positions worth $721M, up 0.67% from $717M the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lisanti Capital Growth withdrew a net $95.8M in Q2 2023, closing 45 positions and reducing 42 holdings. Its most notable exit was Impinj, an estimated $15.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 31% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Lisanti Capital Growth opened a new position in Celsius Holdings worth $11.4M.
- Lisanti Capital Growth's largest Q2 2023 buy was Celsius Holdings: 228,945 shares worth $11.4M.
- Lisanti Capital Growth added most to SPX Corp in Q2 2023, an estimated $7.85M increase.
- Lisanti Capital Growth's biggest Q2 2023 reduction was Samsara, cutting an estimated $10.2M.
- Lisanti Capital Growth fully exited Impinj in Q2 2023, selling an estimated $15.4M.
- Lisanti Capital Growth's ten largest holdings make up 18% of its $721M portfolio in Q2 2023.
- Lisanti Capital Growth opened 72 new positions and closed 45 in Q2 2023.
- Lisanti Capital Growth's portfolio value rose 0.67% quarter-over-quarter to $721M.
Based on Lisanti Capital Growth's 13F filing for Q2 2023, filed 11 Aug 2023.